Skip to content

Clinical Application of Different Sedatives in Intrahospital Transports to Diagnostic Tests of ICU Artificial Airway Patients

Clinical Application of Different Sedatives in Intrahospital Transports to Diagnostic Tests of ICU Artificial Airway Patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045851
Enrollment
Unknown
Registered
2021-04-25
Start date
2021-04-26
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically disease

Interventions

Remimazolam group:Remimazolam
Propofol group:Propofol

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients in the ICU; 2. Intrahospital transport to diagnostic tests; 3. Artificial Airway Patients (Mainly includes transnasal, transoral tracheal intubation and tracheotomy).

Exclusion criteria

Exclusion criteria: 1. Aged = 5.5mmol/L, pH < 7.2; 11. Any situation that hinders the correct evaluation of cognitive function, such as language and sensory disorders or mental disorders (language difficulties or mental organic dysfunction); 12. Patients in need of emergency treatment and rescue; 13. Patients or family members who accidentally come out for inspection or do not agree to be included in the study; 14. Patients who have been included in this study or have been in other studies that may have an impact on this study; 15. Patients with severe liver and kidney dysfunction, such as Childs-Pugh classification as C, KIDGO staging as 3 stages; 16. After trial use of simple ventilator or transfer ventilator for the patient before transfer, SaO2<90% or PaO2<60mmHg; 17. RASS score <-3 points; 18. Patients who meet the selection criteria, but stop the original sedatives and analgesics for 6 hours and still fail to rule out the accumulation of sedatives and analgesics.

Design outcomes

Primary

MeasureTime frame
percentage of target sedation time;

Countries

China

Contacts

Public ContactLiu Wenhua

The Second Affiliated Hospital of Harbin Medical University

liuwenhuaicu@163.com+86 15904616690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026